Fidson Healthcare Plc

Fidson Healthcare Plc is one of Nigeria's leading pharmaceutical manufacturers, listed on the Nigerian Exchange under the symbol FIDSON. The company manufactures and markets a range of branded generic medicines across therapeutic categories including cardiovascular, anti-infectives, analgesics, vitamins and supplements, and anti-malarials. Its manufacturing facility in Sango Ota, Ogun State, is one of the most modern pharmaceutical production plants in West Africa and is certified by the National Agency for Food and Drug Administration and Control (NAFDAC). Fidson has grown significantly over the past decade through product line expansion and capacity investment, and it is regarded as a reference-point indigenous pharmaceutical manufacturer on the NGX.

Fidson Healthcare manufactures branded generic pharmaceutical products across a wide range of therapeutic categories. Products are distributed to hospitals, clinics, pharmacies, and wholesale distributors across Nigeria. The manufacturing plant includes solid dose (tablets and capsules), liquid (syrups and suspensions), and topical (creams and ointments) production capabilities. Fidson also provides contract pharmaceutical manufacturing services to third-party clients. Raw materials — active pharmaceutical ingredients (APIs) and excipients — are primarily imported, making the business sensitive to foreign exchange availability and global API supply dynamics.

Nigeria has a large and growing population with historically low healthcare expenditure per capita — a combination that represents structural growth potential for domestic pharmaceutical manufacturers. Fidson is one of the few NGX-listed companies offering direct exposure to Nigerian pharmaceutical manufacturing, a sector that benefits from increasing local substitution of imported medicines and a naira that makes local production cost-competitive relative to imports when FX is constrained.

• Review the official NGX company profile for FIDSON to confirm listing status, share structure, and recent corporate announcements including any expansion capex or regulatory approvals from NAFDAC.
• Read Fidson's most recent annual report to understand revenue by therapeutic category, gross and operating margin trends, capital expenditure on manufacturing capacity, and the company's debt position relative to EBITDA.
• Assess the Nigerian pharmaceutical regulatory environment — NAFDAC product approvals, importation restrictions on generic medicines, and government healthcare policy — since these can create both tailwinds and compliance risks for domestic manufacturers.

• Foreign exchange risk: Fidson imports a significant share of its active pharmaceutical ingredients and excipients. Naira depreciation increases input costs and can compress margins or require price increases that affect sales volumes.
• Regulatory risk: NAFDAC product registration, manufacturing site inspections, and importation policies directly affect which products Fidson can sell and manufacture. Adverse regulatory actions could disrupt supply.
• Raw material supply risk: global API supply chain disruptions — including from major manufacturing countries — can affect Fidson's ability to maintain production volumes across its product lines.
• Competition: generic pharmaceutical markets are price-competitive. Imported generics and other domestic manufacturers compete on price and availability, particularly in the retail pharmacy channel.
• The value of shares can rise or fall. Past performance of FIDSON is not a guide to future returns.

Fidson Healthcare has declared dividends in periods of strong earnings growth, though dividend payments have not been consistent across all years given capital expenditure requirements for manufacturing capacity expansion. Review the most recent NGX announcements and Fidson annual reports for the current dividend position.

Open a free account, pick Fidson Healthcare Plc and an amount from ₦10,000 a month. We buy through a SEC-regulated broker at the next market open and register the shares in your legal name at the CSCS. Pause or change the amount any month.